Ligand validation:6Y02

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6Y02_GOL_H_305	68%	55%	0.117	0.928	0.76	0.98	-	-	0	0	100%	1
6Y02_GOL_H_309	25%	50%	0.202	0.834	0.98	0.95	-	-	1	0	100%	1
4CH2_GOL_D_1579	69%	41%	0.1	0.914	0.91	1.38	-	1	0	0	100%	1
1XMN_GOL_D_1002	56%	70%	0.143	0.915	0.68	0.47	-	-	0	0	100%	1
3RLW_GOL_H_5	56%	43%	0.145	0.917	1.01	1.21	-	-	0	0	100%	1
1JOU_GOL_B_1001	47%	70%	0.129	0.867	0.75	0.42	-	-	0	0	100%	1
3RLY_GOL_H_4	40%	29%	0.158	0.869	1.04	1.77	-	2	7	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
2Y3G_GOL_A_1150	100%	85%	0.029	0.995	0.36	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.